Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 4 (2007), Issue 3 (March)

1. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
   BMC Genomics, 8: 53. [Abstract] [Full-text]
2. Fluorescence spectroscopy of an in vitro model of human cervical precancer identifies neoplastic phenotype.
   Int J Cancer, 120(9): 1964-70. [Abstract] [Full-text]
3. HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR.
   Int J Cancer, 120(9): 1842-6. [Abstract] [Full-text]
4. Human papillomavirus genotype in cervical cancer: a population-based study.
   Int J Cancer, 120(9): 1999-2006. [Abstract] [Full-text]
5. The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study.
   Virol J, 4: 18. [Abstract] [Full-text]
6. Expression of a novel alternatively spliced variant of NADP(H)-dependent retinol dehydrogenase/reductase with deletion of exon 3 in cervical squamous carcinoma.
   Int J Cancer, 120(8): 1618-26. [Abstract] [Full-text]
7. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18.
   Int J Cancer, 120(8): 1763-8. [Abstract] [Full-text]
8. The "ineffable freemasonry of sex": feminist surgeons and the establishment of radiotherapy in early twentieth-century Britain.
   Bull Hist Med, 81(1): 139-63. [Abstract] [Full-text]
9. Human papillomavirus vaccine: progress and the future.
   Expert Opin Biol Ther, 7(4): 479-85. [Abstract] [Full-text]
10. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
    BMC Cancer, 7: 47. [Abstract] [Full-text]
11. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
    Cancer, 109(7): 1312-22. [Abstract] [Full-text]
12. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
    Nat Clin Pract Oncol, 4(4): 224-35. [Abstract] [Full-text]
13. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study.
    Lancet Oncol, 8(4): 311-6. [Abstract] [Full-text]

© 2004-2008 Cervical Cancer Research Today. All Rights Reserved.